The Lover Lab at UMass-Amherst
Infectious Disease Epidemiology

Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Journal article

Andrew A Lover
MedRXiv, 2020
DOI: https://doi.org/10.1101/2020.03.22.20040949
View PDF
Cite

Cite

APA
Lover, A. A. (2020). Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial. MedRXiv.

Chicago/Turabian
Lover, Andrew A. “Quantifying Treatment Effects of Hydroxychloroquine and Azithromycin for COVID-19: a Secondary Analysis of an Open Label Non-Randomized Clinical Trial.” MedRXiv (2020).

MLA
Lover, Andrew A. “Quantifying Treatment Effects of Hydroxychloroquine and Azithromycin for COVID-19: a Secondary Analysis of an Open Label Non-Randomized Clinical Trial.” MedRXiv, 2020.

Share